Citigroup Other Non-Current Liabilities decreased by 15.3% to $73.18B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.8%, from $66.07B to $73.18B. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows an upward trend with a 7.6% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $62.70B | $75.81B | $74.92B | $94.07B | $86.55B | $87.28B | $87.87B | $76.37B | $79.31B | $69.38B | $75.84B | $71.49B | $69.30B | $68.24B | $68.11B | $66.07B | $74.77B | $74.50B | $86.37B | $73.18B |
| QoQ Change | — | +20.9% | -1.2% | +25.6% | -8.0% | +0.8% | +0.7% | -13.1% | +3.9% | -12.5% | +9.3% | -5.7% | -3.1% | -1.5% | -0.2% | -3.0% | +13.2% | -0.4% | +15.9% | -15.3% |
| YoY Change | — | — | — | — | +38.0% | +15.1% | +17.3% | -18.8% | -8.4% | -20.5% | -13.7% | -6.4% | -12.6% | -1.6% | -10.2% | -7.6% | +7.9% | +9.2% | +26.8% | +10.8% |